Search research articles
Contact Us
Filters
Showing results (331-340 of 548) with videos related to
Page
of 55
Sort By:
Molecular Cancer Therapeutics
|
June 20, 2017
Optimization of <i>RAS/BRAF</i> Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer
Cristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, et al.
Carcinogenesis
|
January 12, 2012
Susceptibility genetic variants associated with early-onset colorectal cancer
María Dolores Giráldez, Adriana López-Dóriga, Luis Bujanda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2014
Dose-response relationship in phase i clinical trials: a European Drug Development Network (EDDN) Collaboration Study
Victor Moreno García, David Olmos, Carlos Gomez-Roca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Jason J Luke, Karen Gelmon, Lillian L Siu, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Albiruni Ra Razak, James M Cleary, Victor Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
Antoine Hollebecque, Hyun C Chung, Maria J de Miguel, et al.
Healthcare (Basel, Switzerland)
|
October 16, 2024
Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors
Alba Marcos-Delgado, Vicente Martín-Sánchez, Ana Molina-Barceló, et al.
Journal of Clinical Medicine
|
April 27, 2024
Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study
Laura Vilà-Quintana, Esther Fort, Laura Pardo, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
Page
of 55
Search research articles
Search
Showing results (331-340 of 548) with videos related to
Sort By:
Page
of 55
Molecular Cancer Therapeutics
|
June 20, 2017
Optimization of <i>RAS/BRAF</i> Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer
Cristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, et al.
Carcinogenesis
|
January 12, 2012
Susceptibility genetic variants associated with early-onset colorectal cancer
María Dolores Giráldez, Adriana López-Dóriga, Luis Bujanda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2014
Dose-response relationship in phase i clinical trials: a European Drug Development Network (EDDN) Collaboration Study
Victor Moreno García, David Olmos, Carlos Gomez-Roca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Jason J Luke, Karen Gelmon, Lillian L Siu, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Albiruni Ra Razak, James M Cleary, Victor Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
Antoine Hollebecque, Hyun C Chung, Maria J de Miguel, et al.
Healthcare (Basel, Switzerland)
|
October 16, 2024
Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors
Alba Marcos-Delgado, Vicente Martín-Sánchez, Ana Molina-Barceló, et al.
Journal of Clinical Medicine
|
April 27, 2024
Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study
Laura Vilà-Quintana, Esther Fort, Laura Pardo, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
Page
of 55